What is the current Revance Therapeutics share price?
The current share price of Revance Therapeutics is US$ 3,07
How many Revance Therapeutics shares are in issue?
Revance Therapeutics has 104.902.388 shares in issue
What is the market cap of Revance Therapeutics?
The market capitalisation of Revance Therapeutics is USD 321M
What is the 1 year trading range for Revance Therapeutics share price?
Revance Therapeutics has traded in the range of US$ 2,30 to US$ 9,745 during the past year
What is the PE ratio of Revance Therapeutics?
The price to earnings ratio of Revance Therapeutics is -0,99
What is the cash to sales ratio of Revance Therapeutics?
The cash to sales ratio of Revance Therapeutics is 1,38
What is the reporting currency for Revance Therapeutics?
Revance Therapeutics reports financial results in USD
What is the latest annual turnover for Revance Therapeutics?
The latest annual turnover of Revance Therapeutics is USD 234,04M
What is the latest annual profit for Revance Therapeutics?
The latest annual profit of Revance Therapeutics is USD -323,99M
What is the registered address of Revance Therapeutics?
The registered address for Revance Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Revance Therapeutics website address?
The website address for Revance Therapeutics is www.revance.com
Which industry sector does Revance Therapeutics operate in?
Revance Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector